Your account is not claimed yet. You can sign up with ORCID to claim your account.

Katarina Nikolic

Loop profile Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 19

Top Venues

Pharmaceuticals (Basel, Switzerland)

Cancers

Future medicinal chemistry

Pharmaceutics

University of Belgarde, Faculty of Pharmacy

University of Belgarde, Faculty of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Belgarde, Faculty of Pharmacy Jul 1o 2007

Serbia

Associate Professor :: Pharmaceutical chemistry

Education History

University of Belgarde, Faculty of Pharmacy Apr 1o 2001 - Apr 17o 2007

Serbia

PHD :: Pharmaceutical chemistry

Publications

Nemanja Djokovic, Minna Rahnasto-Rilla, Nikolaos Lougiakis, Maija Lahtela-Kakkonen, Katarina Nikolic
SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Nemanja Djokovic, Ana Djuric, Dusan Ruzic, Tatjana Srdic-Rajic, Katarina Nikolic
Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Nemanja Djokovic, Minna Rahnasto-Rilla, Nikolaos Lougiakis, Maija Lahtela-Kakkonen, Katarina Nikolic
SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Milan Beljkas, Aleksandra Ilic, Alen Cebzan, Branko Radovic, Nemanja Djokovic, Dusan Ruzic, Katarina Nikolic, Slavica Oljacic
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer. Pharmaceutics 15 (11) (2023)
Nemanja Djokovic, Minna Rahnasto-Rilla, Nikolaos Lougiakis, Maija Lahtela-Kakkonen, Katarina Nikolic
SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Nemanja Djokovic, Minna Rahnasto-Rilla, Nikolaos Lougiakis, Maija Lahtela-Kakkonen, Katarina Nikolic
SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Andrea Bagán, Sergio Rodriguez-Arévalo, Teresa Taboada, Christian Griñán-Ferré, Mercé Pallàs, Iria Brocos-Mosquera, Luis F Callado, Jose Ángel Morales-García, Belén Pérez, Caridad Diaz, Rosario Fernández-Godino, Olga Genilloud, Milan Beljkas, Slavica Oljacic, Katarina Nikolic, Carmen Escolano
Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer's Disease. Pharmaceutics 15 (10) (2023)
Ipek Bulut, Adam Lee, Buse Cevatemre, Dusan Ruzic, Roman Belle, Akane Kawamura, Sheraz Gul, Katarina Nikolic, Arasu Ganesan, Ceyda Acilan
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers 14 (23) (2022)
Nemanja Djokovic, Dusan Ruzic, Minna Rahnasto-Rilla, Tatjana Srdic-Rajic, Maija K Lahtela-Kakkonen, Katarina Nikolic
Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics. Journal of chemical information and modeling 62 (10) (2022)
Milica Radan, Teodora Djikic, Katarina Nikolic
Discovery of new chemotypes of dual 5-HT 2A /D 2 receptor antagonists with a strategy of drug design methodologies. Future medicinal chemistry 14 (13) (2022)
Ipek Bulut, Adam Lee, Buse Cevatemre, Dusan Ruzic, Roman Belle, Akane Kawamura, Sheraz Gul, Katarina Nikolic, Arasu Ganesan, Ceyda Acilan
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers 14 (23) (2022)
Ipek Bulut, Adam Lee, Buse Cevatemre, Dusan Ruzic, Roman Belle, Akane Kawamura, Sheraz Gul, Katarina Nikolic, Arasu Ganesan, Ceyda Acilan
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers 14 (23) (2022)
Corentin Bon, Magdalena Barbachowska, Nemanja Djokovic, Dusan Ruzic, Yang Si, Laura Soresinetti, Corinne Jallet, Ambre Tafit, Ludovic Halby, Katarina Nikolic, Paola Barbara Arimondo
Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies. Future medicinal chemistry 14 (8) (2022)
Milica Elek, Nemanja Djokovic, Annika Frank, Slavica Oljacic, Aleksandra Zivkovic, Katarina Nikolic, Holger Stark
Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands. Archiv der Pharmazie 354 (6) (2021)
Teodora Djikic, Jelica Vucicevic, Jonne Laurila, Marco Radi, Nevena Veljkovic, Henri Xhaard, Katarina Nikolic
Deciphering Imidazoline Off-targets by Fishing in the Class A of GPCR field. Molecular informatics 39 (7) (2020)
Dusan Ruzic, Milos Petkovic, Danica Agbaba, A Ganesan, Katarina Nikolic
Combined Ligand and Fragment-based Drug Design of Selective Histone Deacetylase - 6 Inhibitors. Molecular informatics 38 (5) (2019)
Strahinja Stevanovic, Milan Sencanski, Mathieu Danel, Christophe Menendez, Roumaissa Belguedj, Abdelmalek Bouraiou, Katarina Nikolic, Sandrine Cojean, Philippe M Loiseau, Sanja Glisic, Michel Baltas, Alfonso T García-Sosa
Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-Targets. Molecules (Basel, Switzerland) 24 (7) (2019)
Marija Čarapić, Katarina Nikolic, Bojan Marković, Miloš Petković, Milena Pavlovic, Danica Agbaba
Ultra-performance liquid chromatography tandem mass spectrometry for the rapid, simultaneous analysis of ziprasidone and its impurities. Biomedical chromatography : BMC 33 (2) (2018)
Slavica Oljacic, Milica Elek, Marija R Popović-Nikolić, Katarina Nikolic, Danica Agbaba
Development of Hydrophilic Interaction Liquid Chromatography Method for the Analysis of Moxonidine and Its Impurities. Journal of analytical methods in chemistry 2016 (2016)

Katarina Nikolic.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Katarina Nikolic